TrialInflammopharmacology2021

Colchicine effectively attenuates inflammatory biomarker high-sensitivity C-reactive protein (hs-CRP) in patients with non-ST-segment elevation myocardial infarction: a randomised, double-blind, placebo-controlled clinical trial.

Arash Gholoobi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.